Meng‐Ling Wu

1.7k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Meng‐Ling Wu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Meng‐Ling Wu has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Meng‐Ling Wu's work include Autophagy in Disease and Therapy (5 papers), Cell Adhesion Molecules Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Meng‐Ling Wu is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Cell Adhesion Molecules Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Meng‐Ling Wu collaborates with scholars based in China, Taiwan and United States. Meng‐Ling Wu's co-authors include Shaw‐Fang Yet, Yen‐Chun Ho, Yong Xia, Yiwen Zhang, Hongbo Ma, Yao Xie, Chen‐Yu Lin, Jun Ma, Michael Bigby and Man‐Sun Sy and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and ACS Nano.

In The Last Decade

Meng‐Ling Wu

35 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

2022 308 citations Meng‐Ling Wu, Yao Xie et al. Journal of Hematology & Oncology profile →

Peers

Meng‐Ling Wu

ONCOL

IMMUN

PRM

Damiano Cosimo Rigiracciolo Italy

Chung‐Sheng Shi Taiwan

Wei Fu China

Peihua Luo China

Kumaravelu Jagavelu India

Xiaoxian Zhao United States

Xia Zhao China

Wei Tian China

Zhimin Tong United States

Man Wu China

Damiano Cosimo Rigiracciolo Italy

Meng‐Ling Wu

681 ×1.1

371 ×1.1

ONCOL

151 ×0.6

IMMUN

111 ×0.6

PRM

301 ×1.7

Citations per year, relative to Meng‐Ling Wu Meng‐Ling Wu (= 1×) peers Damiano Cosimo Rigiracciolo

Countries citing papers authored by Meng‐Ling Wu

Since Specialization

Citations

This map shows the geographic impact of Meng‐Ling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Ling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Ling Wu more than expected).

Fields of papers citing papers by Meng‐Ling Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Ling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Ling Wu. The network helps show where Meng‐Ling Wu may publish in the future.

Co-authorship network of co-authors of Meng‐Ling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Ling Wu. A scholar is included among the top collaborators of Meng‐Ling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Ling Wu. Meng‐Ling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Wen, Hang Chen, Xiangqian Jia, et al.. (2025). Barcoded screening identifies nanocarriers for protein delivery to kidney. Nature Communications. 16(1). 899–899. 6 indexed citations

Zhang, Qian, Yang Yang, Meng‐Ling Wu, et al.. (2025). Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy. Advanced Science. e09638–e09638.

Wu, Meng‐Ling, et al.. (2024). Inhibition of TNBC Cell Growth by Paroxetine: Induction of Apoptosis and Blockage of Autophagy Flux. Cancers. 16(5). 885–885. 3 indexed citations

Zhang, Yaning, et al.. (2024). Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation. Cell Reports Medicine. 5(11). 101800–101800. 3 indexed citations

He, Anqi, et al.. (2024). The Influence of Exercise on Cancer Risk, the Tumor Microenvironment and the Treatment of Cancer. Sports Medicine. 54(6). 1371–1397. 6 indexed citations

Wu, Meng‐Ling, et al.. (2024). Fluoxetine as a Potential Therapeutic Agent for Inhibiting Melanoma Brain and Lung Metastasis: Induction of Apoptosis, G0/G1 Cell Cycle Arrest, and Disruption of Autophagy Flux. Journal of Cancer. 15(12). 3825–3840. 1 indexed citations

Jia, Xiangqian, Hang Chen, Meng‐Ling Wu, et al.. (2023). A Biodegradable Antigen Nanocapsule Promotes Anti‐Tumor Immunity via the cGAS‐STING Pathway. Advanced Functional Materials. 33(10). 9 indexed citations

Schafer, Christopher M., Silvia Martin‐Almedina, Neil Dufton, et al.. (2023). Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge. Arteriosclerosis Thrombosis and Vascular Biology. 43(8). 1412–1428. 9 indexed citations

Wu, Meng‐Ling, et al.. (2023). Dual-Specificity Phosphatase 6 Deficiency Attenuates Arterial-Injury-Induced Intimal Hyperplasia in Mice. International Journal of Molecular Sciences. 24(24). 17136–17136. 2 indexed citations

10.

Wu, Meng‐Ling, et al.. (2023). Repurposing fluphenazine to suppress melanoma brain, lung and bone metastasis by inducing G0/G1 cell cycle arrest and apoptosis and disrupting autophagic flux. Clinical & Experimental Metastasis. 40(2). 161–175. 6 indexed citations

11.

Wu, Meng‐Ling, et al.. (2022). OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis. Cellular Oncology. 45(6). 1255–1275. 6 indexed citations

12.

Xu, Fuyan, Yiqian Zhang, Hongbo Ma, et al.. (2022). Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy. Cancer Chemotherapy and Pharmacology. 89(3). 331–346. 26 indexed citations

13.

Wu, Meng‐Ling, et al.. (2022). Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(5). 188761–188761. 59 indexed citations

14.

Wu, Meng‐Ling, et al.. (2022). Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. Journal of Hematology & Oncology. 15(1). 24–24. 308 indexed citations breakdown →

15.

Wu, Meng‐Ling, Yen‐Chun Ho, Ming‐Hsien Tsai, et al.. (2020). Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration. International Journal of Molecular Sciences. 21(10). 3437–3437. 19 indexed citations

16.

Su, Guohai, Lianghong Yin, Yan Xing, et al.. (2020). PCV6 MODEL-Based Evaluation on Annual Economic Burden of Coronary Atherosclerotic Heart Disease in China. Value in Health Regional Issues. 22. S27–S27. 1 indexed citations

17.

Wang, Jing, et al.. (2018). Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling. Biomedicine & Pharmacotherapy. 107. 1074–1081. 42 indexed citations

18.

Li, Ziqian, Yifei Qi, Linlin Lu, et al.. (2017). Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance. Cancer Research and Treatment. 50(3). 894–907. 38 indexed citations

19.

Wu, Meng‐Ling, Matthew D. Layne, & Shaw‐Fang Yet. (2012). Heme oxygenase-1 in environmental toxin-induced lung disease. Toxicology Mechanisms and Methods. 22(5). 323–329. 21 indexed citations

20.

Lin, Dawei, Il‐Chi Chang, Alan Tseng, et al.. (2008). Transforming Growth Factor β Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2. Journal of Biological Chemistry. 283(22). 15003–15014. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact